Our finding that GRP78 knockdown decreased the phosphorylation of c-Jun and inhibited the translocation of AP-1 complex into nucleus. These data suggested that c-Jun was the downstream transcription factor in the reduced MMP2 activity caused by GRP78 knockdown. Overall, our data revealed a mechanism by which GRP78 knockdown inhibits the ECM degradation and the activity and expression of MMP-2. JNK-c-Jun signaling pathway play important role in this process. This finding suggested that GRP78 may be a potential target

for the prevention of the invasion and metastasis of this website hepatocellular carcinoma. Materials and methods Antibodies The primary antibodies used were: GRP78 (sc-1051), GRP94 (sc-1794), MMP-2 (CST-4022), MMP-9 (CST-3852), MMP-14 (ab3644), TIMP-1 (CST-8946), TIMP-2 (sc-21735), FAK (396500, Biosource), FAK-pY397 (44625 G, Biosource), JNK (sc-7345), Src(CST-2123), selleck inhibitor Src-pY416(CST-6943), p-JNK (sc-6354), c-Jun (CST-9165), p-c-Jun (CST-9261). HRP-conjugated secondary antibodies were purchased from Zhongshan Company

(Beijing, China). Cell culture Human hepatocellular carcinoma cell line SMMC7721 and HepG2 were purchased from the Type Culture Collection of Chinese Academy of Science. The cells were propagated in complete DMEM medium supplemented with 10% fetal bovine serum(FBS), BMS-907351 clinical trial 2 mM glutamine, 100 U/ml penicillin, 100ug/ml streptomycin at 37°C, 5% CO2 -95% O2 and passaged every 3–5 days. GRP78-shRNAs transfection into SMMC-7721 The pEGFP-N1-GRP78-shRNAs were purchased from the Genechem Company (Shanghai, China). The sequences were shown as follows, all sequences were provided in 5’ → 3’ direction: 1th: Sense: caGCATCAAGCAAGAATTGAA Antisense: TTCAATTCTTGCTTGATGCtg 2th: Sense: gaCCTGGTACTGCTTGATGTA Antisense: TACATCAAGCAGTACCAGGtc 3th: Sense: aaGGAGCGCATTGATACTAGA Antisense: TCTAGTATCAATGCGCTCCtt 4th: Sense: aaGCAACCAAAGACGCTGGAA Antisense: TTCCAGCGTCTTTGGTTGCtt Transfection was performed using Lipofectamine™ 2000(Invitrogen) as the manufacture’s instruction. Briefly, the logarithmically growing cells

were plated in 6-well plate in 2000 μl of DMEM complete growth medium without antibiotics science and with serum. After 24 h, 10 μl of Lipofectamine™ 2000 was diluted to 250 μl by serum-free medium, mixed with DNA solution (4 μg DNA in 250 μl serum-free medium) in a sterile 1.5 ml EP tube and incubated for 30 min at room temperature. The mixture was added drop by drop into each well, incubated for 72 h under normal cell culture conditions. pEGFP-N1 was transfected at the same time as control. The transfection efficiency was observed by fluorescent microscope and the effect of GRP78-shRNAs was determined by western blot. Establishment of cells that stably expressing GRP78-shRNAs Selection of SMMC-7721 cells stably expressing GRP78-shRNAs was performed according to the manufacturer’s instructions (Invitrogen).